As Head of Clinical Operations for Marengo Therapeutics, Alyssa Marino is responsible for building the operational foundation of the Clinical Development Organization and delivering pioneering study execution methods. Alyssa brings over two decades of experience overseeing the execution of multiple clinical programs in early oncology. She has held several roles of increasing responsibility with companies such as Organogenesis, Sanofi-Genzyme, Novartis, Merck-Serono, and H3 Biomedicine, where she directed several clinical operations groups and mentored those new to clinical development operations, ensuring that work in clinical research could reach new heights. Alyssa’s passion is advancing early drug candidates into the clinic within a quality framework, bringing us one step closer to helping more patients beat cancer.

Alyssa holds a BA from Boston College and CCRA from the Association of Clinical Research Professionals.